Fresenius SE Debt to Equity Ratio 2016-2024 | FSNUY

Current and historical debt to equity ratio values for Fresenius SE (FSNUY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fresenius SE debt/equity for the three months ending June 30, 2024 was 0.56.
Fresenius SE Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $25.75B $21.11B 1.22
2024-03-31 $26.24B $21.84B 1.20
2023-12-31 $27.74B $21.27B 1.30
2023-09-30 $49.03B $32.96B 1.49
2023-06-30 $49.05B $34.27B 1.43
2023-03-31 $47.64B $34.54B 1.38
2022-12-31 $46.57B $33.95B 1.37
2022-09-30 $46.50B $34.40B 1.35
2022-06-30 $46.91B $34.09B 1.38
2022-03-31 $47.73B $34.32B 1.39
2021-12-31 $50.49B $34.65B 1.46
2021-09-30 $50.58B $33.24B 1.52
2021-06-30 $51.23B $32.69B 1.57
2021-03-31 $49.98B $33.17B 1.51
2020-12-31 $46.40B $29.73B 1.56
2020-09-30 $49.24B $30.63B 1.61
2020-06-30 $46.58B $30.01B 1.55
2020-03-31 $46.35B $29.74B 1.56
2019-12-31 $45.28B $29.77B 1.52
2019-09-30 $44.55B $29.69B 1.50
2019-06-30 $44.45B $28.53B 1.56
2019-03-31 $44.47B $29.34B 1.52
2018-12-31 $48.77B $18.20B 2.68
2018-09-30 $47.56B $17.23B 2.76
2018-06-30 $48.42B $17.15B 2.82
2018-03-31 $48.70B $17.07B 2.85
2017-12-31 $35.51B $24.55B 1.45
2017-09-30 $37.53B $24.88B 1.51
2017-06-30 $35.06B $23.12B 1.52
2017-03-31 $34.63B $23.36B 1.48
2016-12-31 $28.80B $22.60B 1.28
2016-09-30 $27.65B $21.12B 1.31
2016-06-30 $28.65B $20.85B 1.37
2016-03-31 $26.96B $19.87B 1.36
2015-12-31 $27.95B $19.99B 1.40
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Chemed (CHE) United States $8.593B 26.41
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00